Has David Anderson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $786,220 in general payments to David Anderson, MD across 101 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Anderson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Anderson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Anderson, MD

Orthopaedic Surgery of the Spine · Bensalem, PANPI 1497792725

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $732,894 of the $786,220 with a category attached, or 93.2%. 9 manufacturers reported payments, led by Depuy Synthes Products, Inc. at 52.3% of the total. Reporting peaked in 2019 at $308,964 and has fallen 84.0% since, to $49,398 in 2024. Among orthopaedic surgery of the spine clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$786,220in general payments, 2019–2025

Across 101 payments — averaging $7784.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Depuy Synthes Products, Inc.$411K
Integrity Implants Inc.$216K
Integrity Implants Inc. Dba Accelus$106K
Surgalign Spine Technologies, Inc.$53K
The Institute Of Musculoskeletal Science And Education$156
Mirus, LLC$150
plus $346 from 3 others

$25,825in research payments, 2019–2025

Across 7 payments — averaging $3689.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Innovative Surgical Designs, Inc.$15K
Biotissue Holdings Inc.$6K
Relievant Medsystems, Inc.$4K

$200,353in ownership & investment interests, 2019–2025

Across 9 payments — averaging $22,261 each. An ownership or investment interest held by the physician or an immediate family member.

Durastat LLC$200K
Innovative Surgical Designs, Inc.$0

What the payments were for

Royalty or licence$732,89493%
Consulting fees$42,9075%
Travel & lodging$9,1801%
Food & beverage$1,1760%
Education$100%
Gifts$540%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Depuy Synthes Products, Inc.	2	$410,838
Integrity Implants Inc.	16	$215,946
Integrity Implants Inc. Dba Accelus	8	$106,155
Surgalign Spine Technologies, Inc.	68	$52,630
The Institute Of Musculoskeletal Science And Education	1	$156
Mirus, LLC	2	$150
Acuity Surgical Devices, LLC	2	$149
4web, Inc.	1	$123
Stryker	1	$74

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$786,220 in reported general payments places this provider in the 90th percentile of 43 orthopaedic surgery of the spine providers in Pennsylvania.

See all orthopaedic surgery of the spine providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$11,075

Medicare patients

Services billed

129

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	55	$628
Tramadol Hcl	12	$19

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Bensalem

Alan HilibrandBensalem$1.4M
Joel TorrettiState College$1.1M
Gregory BaileyState College$1.1M
Jeffrey McConnellAllentown$509K
Christopher HendersonDickson City$222K
Joshua PahysPhiladelphia$213K
David CasperPhiladelphia$195K
Scott RushtonWynnewood$93K
Eric EmanskiState College$88K
Usman ZahirYork$55K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →